Picture of Avinger logo

AVGR — Avinger News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Avinger - Revenue In Q1 2020 Is Expected To Be Approximately $2.25 Million, Up 22%

April 15 (Reuters) - Avinger Inc  AVGR.O :
    * AVINGER - REVENUE IN Q1 2020 IS EXPECTED TO BE
APPROXIMATELY
$2.25 MILLION, UP 22%
    * AVINGER - EXPECTS A DECLINE IN OVERALL CASE VOLUME AND
SALES OF
ITS PRODUCTS TO CONTINUE THROUGH Q2 2020
    * AVINGER - IMPLEMENTED SERIES OF COST REDUCTIONS IN Q2,
INCLUDING
20% SALARY REDUCTION COMPANY-WIDE
    * AVINGER - IMPLEMENTED SERIES OF COST REDUCTIONS IN Q2,
INCLUDING
REDUCTION IN HOURS WORKED BY MANUFACTURING AND OTHER HOURLY
EMPLOYEES
    * AVINGER - IMPLEMENTED SERIES OF COST REDUCTIONS IN Q2,
INCLUDING
DISCRETIONARY SPENDING CUTS ACROSS THE ORGANIZATION
    * AVINGER - CONTINUES TO ADVANCE KEY PRODUCT DEVELOPMENT
PROGRAMS,
DOES NOT EXPECT TIMELINES FOR THESE PROGRAMS TO BE IMPACTED BY
COVID-19
    * AVINGER - IN RESPONSE TO COVID-19 PANDEMIC, ADDITIONAL
PATIENT
ENROLLMENT AND SITE INITIATION HAS BEEN PAUSED FOR IMAGE-BTK
STUDY

Source text: [https://bit.ly/2yfaTZC]
Further company coverage:  AVGR.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Avinger

See all news